Back
Day Range
$103.78
$107.17
52-Week Range
$73.16
$130.23
Volume
630,887
50D / 200D Avg
$113.40
/
$99.38
Prev Close
$106.84
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -32.6 | 0.3 |
| P/B | 9.3 | 2.9 |
| ROE % | -26.4 | 3.7 |
| Net Margin % | -37.0 | 3.8 |
| Rev Growth 5Y % | 14.6 | 10.0 |
| D/E | 0.2 | 0.2 |
Analyst Price Target
Hold
$143.44
+36.3%
Low: $127.00
High: $165.00
Forward EPS
-$0.56
Est. Revenue
610 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$4.32
$4.13 – $4.48
|
1.5 B | 2 |
| FY2029 |
$2.62
$2.51 – $2.72
|
1.3 B | 4 |
| FY2028 |
$1.56
$1.17 – $2.12
|
1 B | 6 |
Key Takeaways
Revenue grew 14.62% annually over 5 years — strong growth
Debt/Equity of 0.21 — conservative balance sheet
Negative free cash flow of -54.01M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 17.71%
Capital efficient — spends only 1.51% of revenue on capex
Growth
Revenue Growth (5Y)
14.62%
Revenue (1Y)32.33%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-26.38%
ROIC-18.81%
Net Margin-36.99%
Op. Margin-39.33%
Safety
Debt / Equity
0.21
Current Ratio4.69
Interest Coverage-43.06
Valuation
P/E Ratio
-32.56
P/B Ratio9.31
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 32.33% | Revenue Growth (3Y) | 26.98% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 14.62% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 507.44M | Net Income (TTM) | -187.69M |
| ROE | -26.38% | ROA | -21.01% |
| Gross Margin | 55.72% | Operating Margin | -39.33% |
| Net Margin | -36.99% | Free Cash Flow (TTM) | -54.01M |
| ROIC | -18.81% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.21 | Current Ratio | 4.69 |
| Interest Coverage | -43.06 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -32.56 | P/B Ratio | 9.31 |
| P/S Ratio | 12.04 | PEG Ratio | -1.87 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 6.11B | Enterprise Value | 6.16B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 507.44M | 383.48M | 314.71M | 282.86M | 294.01M |
| Net Income | -187.69M | -146.37M | -134.66M | -99.20M | -49.59M |
| EPS (Diluted) | -3.28 | -2.77 | -2.78 | -2.09 | -1.07 |
| Gross Profit | 282.76M | 289.45M | 239.14M | 213.88M | 227.38M |
| Operating Income | -199.60M | -122.37M | -128.70M | -82.31M | -32.87M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 893.49M | 974.76M | 940.41M | 1.07B | 1.13B |
| Total Liabilities | 237.33M | 207.83M | 478.65M | 544.16M | 541.68M |
| Shareholders' Equity | 656.16M | 766.93M | 461.77M | 530.01M | 587.15M |
| Total Debt | 139.64M | 105.87M | 383.74M | 382.91M | 383.39M |
| Cash & Equivalents | 90.81M | 169.63M | 93.47M | 119.53M | 100.71M |
| Current Assets | 474.98M | 449.79M | 395.46M | 443.86M | 486.13M |
| Current Liabilities | 101.28M | 75.13M | 74.01M | 72.36M | 63.36M |